Sally Hopkins-Donaldson
Overview
Explore the profile of Sally Hopkins-Donaldson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
161
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kallio J, Hopkins-Donaldson S, Baker A, Kahari V
Int J Cancer
. 2010 May;
128(4):991-6.
PMID: 20473894
Tissue inhibitor of metalloproteinases-3 (TIMP-3) has previously been identified as a tumor suppressor for adherent malignant and normal cells. TIMP-3 inhibits adhesion of cells to extracellular matrix and promotes apoptosis...
2.
Belyanskaya L, Ziogas A, Hopkins-Donaldson S, Kurtz S, Simon H, Stahel R, et al.
Lung Cancer
. 2007 Dec;
60(3):355-65.
PMID: 18093694
Small cell lung cancer (SCLC) is characterized by an aggressive phenotype and acquired resistance to a broad spectrum of anticancer agents. TNF-related apoptosis-inducing ligand (TRAIL) has been considered as a...
3.
Belyanskaya L, Marti T, Hopkins-Donaldson S, Kurtz S, Felley-Bosco E, Stahel R
Mol Cancer
. 2007 Oct;
6:66.
PMID: 17953743
Background: The incidence of malignant pleural mesothelioma (MPM) is associated with exposure to asbestos, and projections suggest that the yearly number of deaths in Western Europe due to MPM will...
4.
Hopkins-Donaldson S, Belyanskaya L, Simoes-Wust A, Sigrist B, Kurtz S, Zangemeister-Wittke U, et al.
Neoplasia
. 2006 Jul;
8(7):551-9.
PMID: 16867217
Malignant pleural mesotheliomas (MPMs) are usually wild type for the p53 gene but contain homozygous deletions in the INK4A locus that encodes p14(ARF), an inhibitor of p53-MDM2 interaction. Previous findings...
5.
Belyanskaya L, Hopkins-Donaldson S, Kurtz S, Simoes-Wust A, Yousefi S, Simon H, et al.
Int J Cancer
. 2005 Jun;
117(5):755-63.
PMID: 15981204
The inhibitor of apoptosis protein (IAP) survivin is overexpressed in many tumors but is absent in most normal adult tissues. We report high levels of survivin expression in small cell...
6.
Zangemeister-Wittke U, Hopkins-Donaldson S
Lung Cancer
. 2005 May;
49 Suppl 1:S105-8.
PMID: 15888351
No abstract available.
7.
Simoes-Wust A, Hopkins-Donaldson S, Sigrist B, Belyanskaya L, Stahel R, Zangemeister-Wittke U
Oligonucleotides
. 2005 Jan;
14(3):199-209.
PMID: 15625915
We previously reported the Bcl-2/Bcl-xL-bispecific activity of the 2'-O-(2-methoxy)ethyl (2'-MOE)-modified gapmer antisense oligonucleotide 4625. This oligonucleotide has 100% complementarity to Bcl-2 and three mismatches to Bcl-xL. In the present study,...
8.
Hopkins-Donaldson S, Cathomas R, Simoes-Wust A, Kurtz S, Belyanskaya L, Stahel R, et al.
Int J Cancer
. 2003 Jun;
106(2):160-6.
PMID: 12800189
Our study was designed to investigate the role of the anti-apoptotic proteins Bcl-2 and Bcl-xL in the chemoresistance of cells derived from malignant pleural mesothelioma. First, we determined the basal...
9.
Hopkins-Donaldson S, Yan P, Balmas Bourloud K, Muhlethaler A, Bodmer J, Gross N
Oncogene
. 2002 Aug;
21(39):6132-7.
PMID: 12203125
Death induced by doxorubicin (dox) in neuroblastoma (NB) cells was originally thought to occur via the Fas pathway, however since studies suggest that caspase-8 expression is silenced in most high...